FDA Inspection 1056627 — Lupin Limited
The FDA completed an inspection of Lupin Limited on May 11, 2018 in Nagpur. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nagpur (India)